vs

Side-by-side financial comparison of Invesco (IVZ) and Primoris Services Corp (PRIM). Click either name above to swap in a different company.

Primoris Services Corp is the larger business by last-quarter revenue ($1.9B vs $1.7B, roughly 1.1× Invesco). Primoris Services Corp runs the higher net margin — 2.8% vs -58.9%, a 61.6% gap on every dollar of revenue. On growth, Primoris Services Corp posted the faster year-over-year revenue change (6.7% vs 6.2%). Invesco produced more free cash flow last quarter ($432.2M vs $121.1M). Over the past eight quarters, Primoris Services Corp's revenue compounded faster (14.7% CAGR vs 7.1%).

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

Primoris Services Corporation is a publicly traded specialty construction and infrastructure company based in the United States, with a particular focus on pipelines for natural gas, wastewater and water. As of 2014 it was a Fortune 1000 company.

IVZ vs PRIM — Head-to-Head

Bigger by revenue
PRIM
PRIM
1.1× larger
PRIM
$1.9B
$1.7B
IVZ
Growing faster (revenue YoY)
PRIM
PRIM
+0.5% gap
PRIM
6.7%
6.2%
IVZ
Higher net margin
PRIM
PRIM
61.6% more per $
PRIM
2.8%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$311.1M more FCF
IVZ
$432.2M
$121.1M
PRIM
Faster 2-yr revenue CAGR
PRIM
PRIM
Annualised
PRIM
14.7%
7.1%
IVZ

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IVZ
IVZ
PRIM
PRIM
Revenue
$1.7B
$1.9B
Net Profit
$-995.9M
$51.7M
Gross Margin
9.4%
Operating Margin
-86.2%
4.2%
Net Margin
-58.9%
2.8%
Revenue YoY
6.2%
6.7%
Net Profit YoY
-575.8%
-4.2%
EPS (diluted)
$-2.61
$0.94

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVZ
IVZ
PRIM
PRIM
Q4 25
$1.7B
$1.9B
Q3 25
$1.6B
$2.2B
Q2 25
$1.5B
$1.9B
Q1 25
$1.5B
$1.6B
Q4 24
$1.6B
$1.7B
Q3 24
$1.5B
$1.6B
Q2 24
$1.5B
$1.6B
Q1 24
$1.5B
$1.4B
Net Profit
IVZ
IVZ
PRIM
PRIM
Q4 25
$-995.9M
$51.7M
Q3 25
$356.4M
$94.6M
Q2 25
$197.4M
$84.3M
Q1 25
$171.1M
$44.2M
Q4 24
$209.3M
$54.0M
Q3 24
$55.0M
$58.4M
Q2 24
$132.2M
$49.5M
Q1 24
$141.5M
$18.9M
Gross Margin
IVZ
IVZ
PRIM
PRIM
Q4 25
9.4%
Q3 25
10.8%
Q2 25
12.3%
Q1 25
10.4%
Q4 24
10.6%
Q3 24
12.0%
Q2 24
11.9%
Q1 24
9.4%
Operating Margin
IVZ
IVZ
PRIM
PRIM
Q4 25
-86.2%
4.2%
Q3 25
16.5%
6.3%
Q2 25
14.1%
6.7%
Q1 25
18.1%
4.3%
Q4 24
19.6%
5.0%
Q3 24
6.6%
6.0%
Q2 24
13.9%
5.5%
Q1 24
14.4%
3.1%
Net Margin
IVZ
IVZ
PRIM
PRIM
Q4 25
-58.9%
2.8%
Q3 25
21.7%
4.3%
Q2 25
13.0%
4.5%
Q1 25
11.2%
2.7%
Q4 24
13.1%
3.1%
Q3 24
3.6%
3.5%
Q2 24
8.9%
3.2%
Q1 24
9.6%
1.3%
EPS (diluted)
IVZ
IVZ
PRIM
PRIM
Q4 25
$-2.61
$0.94
Q3 25
$0.66
$1.73
Q2 25
$-0.03
$1.54
Q1 25
$0.38
$0.81
Q4 24
$0.46
$0.98
Q3 24
$0.12
$1.07
Q2 24
$0.29
$0.91
Q1 24
$0.31
$0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVZ
IVZ
PRIM
PRIM
Cash + ST InvestmentsLiquidity on hand
$1.0B
$535.5M
Total DebtLower is stronger
$1.8B
$469.9M
Stockholders' EquityBook value
$12.2B
$1.7B
Total Assets
$27.1B
$4.4B
Debt / EquityLower = less leverage
0.15×
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVZ
IVZ
PRIM
PRIM
Q4 25
$1.0B
$535.5M
Q3 25
$973.1M
$431.4M
Q2 25
$922.7M
$390.3M
Q1 25
$821.7M
$351.6M
Q4 24
$986.5M
$455.8M
Q3 24
$1.0B
$352.7M
Q2 24
$878.5M
$207.4M
Q1 24
$895.7M
$177.6M
Total Debt
IVZ
IVZ
PRIM
PRIM
Q4 25
$1.8B
$469.9M
Q3 25
$1.6B
$486.0M
Q2 25
$1.9B
$603.1M
Q1 25
$964.8M
$612.0M
Q4 24
$890.6M
$734.8M
Q3 24
$890.3M
$903.7M
Q2 24
$890.1M
$933.0M
Q1 24
$1.3B
$951.7M
Stockholders' Equity
IVZ
IVZ
PRIM
PRIM
Q4 25
$12.2B
$1.7B
Q3 25
$14.0B
$1.6B
Q2 25
$13.9B
$1.5B
Q1 25
$14.7B
$1.4B
Q4 24
$14.6B
$1.4B
Q3 24
$14.8B
$1.4B
Q2 24
$14.6B
$1.3B
Q1 24
$14.6B
$1.2B
Total Assets
IVZ
IVZ
PRIM
PRIM
Q4 25
$27.1B
$4.4B
Q3 25
$28.4B
$4.6B
Q2 25
$28.5B
$4.5B
Q1 25
$28.1B
$4.2B
Q4 24
$27.0B
$4.2B
Q3 24
$27.5B
$4.2B
Q2 24
$27.2B
$4.0B
Q1 24
$28.1B
$4.0B
Debt / Equity
IVZ
IVZ
PRIM
PRIM
Q4 25
0.15×
0.28×
Q3 25
0.12×
0.30×
Q2 25
0.14×
0.39×
Q1 25
0.07×
0.42×
Q4 24
0.06×
0.52×
Q3 24
0.06×
0.67×
Q2 24
0.06×
0.72×
Q1 24
0.09×
0.76×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVZ
IVZ
PRIM
PRIM
Operating Cash FlowLast quarter
$455.8M
$142.9M
Free Cash FlowOCF − Capex
$432.2M
$121.1M
FCF MarginFCF / Revenue
25.5%
6.5%
Capex IntensityCapex / Revenue
1.4%
1.2%
Cash ConversionOCF / Net Profit
2.76×
TTM Free Cash FlowTrailing 4 quarters
$1.4B
$340.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVZ
IVZ
PRIM
PRIM
Q4 25
$455.8M
$142.9M
Q3 25
$606.2M
$182.9M
Q2 25
$547.9M
$78.5M
Q1 25
$-84.6M
$66.2M
Q4 24
$316.9M
$298.3M
Q3 24
$438.4M
$222.5M
Q2 24
$489.1M
$16.1M
Q1 24
$-54.4M
$-28.5M
Free Cash Flow
IVZ
IVZ
PRIM
PRIM
Q4 25
$432.2M
$121.1M
Q3 25
$586.4M
$148.4M
Q2 25
$530.4M
$45.3M
Q1 25
$-108.0M
$25.6M
Q4 24
$309.9M
$270.0M
Q3 24
$410.0M
$158.8M
Q2 24
$462.4M
$-8.1M
Q1 24
$-75.4M
$-38.9M
FCF Margin
IVZ
IVZ
PRIM
PRIM
Q4 25
25.5%
6.5%
Q3 25
35.7%
6.8%
Q2 25
35.0%
2.4%
Q1 25
-7.1%
1.6%
Q4 24
19.5%
15.5%
Q3 24
27.1%
9.6%
Q2 24
31.2%
-0.5%
Q1 24
-5.1%
-2.8%
Capex Intensity
IVZ
IVZ
PRIM
PRIM
Q4 25
1.4%
1.2%
Q3 25
1.2%
1.6%
Q2 25
1.2%
1.8%
Q1 25
1.5%
2.5%
Q4 24
0.4%
1.6%
Q3 24
1.9%
3.9%
Q2 24
1.8%
1.5%
Q1 24
1.4%
0.7%
Cash Conversion
IVZ
IVZ
PRIM
PRIM
Q4 25
2.76×
Q3 25
1.70×
1.93×
Q2 25
2.78×
0.93×
Q1 25
-0.49×
1.50×
Q4 24
1.51×
5.53×
Q3 24
7.97×
3.81×
Q2 24
3.70×
0.32×
Q1 24
-0.38×
-1.50×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

PRIM
PRIM

Energy Segment$1.2B64%
Unit Price Contracts$473.7M25%
Cost Reimbursable Contracts$121.3M7%
Other$74.9M4%

Related Comparisons